Tarlatamab-dlle (Imdelltra) demonstrated a manageable security profile and early antitumor exercise in sufferers with DLL3-expressing neuroendocrine prostate most cancers (NEPC), in line with...
GE HealthCare Applied sciences’ Inc. GEHC MIM Software program not too long ago launched the MIM Symphony HDR Prostate to assist excessive dose-rate (HDR)...